Abbott. 2.2.1 Abbott will carry out a maximum of ten different trial▇ ▇▇▇▇g its ▇▇ltrex(TM) Technology, focusing on [**] 2.2.2 Abbott will carry out preliminary stability testing of the Meltrex(T▇) formulations at [**] 2.2.3 In parallel with the above steps, Abbott will also perform process analysis of the Meltrex(TM) f▇▇▇▇▇▇tions [**]
Appears in 1 contract
Sources: Development and Supply Agreement (Barrier Therapeutics Inc)
Abbott. 2.2.1 Abbott will carry out a maximum of ten different trial▇▇▇ ▇▇▇▇g fferent trials using its ▇▇ltrex(TMMeltrex(TM) Technology, focusing on [**]
2.2.2 Abbott will carry out preliminary stability testing of the Meltrex(T▇Meltrex(TM) formulations at [**]
2.2.3 In parallel with the above steps, Abbott will also perform process analysis of the Meltrex(TM) f▇▇▇▇▇▇tions formulations [**]
Appears in 1 contract
Sources: Development and Supply Agreement (Barrier Therapeutics Inc)